Presenters at the recent San Antonio Breast Cancer Symposium (SABCS; December 5–9, 2017) reported the latest findings in breast cancer research. NEJM Journal Watch Oncology and Hematology Editor-in-Chief Dr. William Gradishar was on hand to summarize results of the key studies. For more information on the meeting, please visit the SABCS website, and for access to the abstracts, please visit the abstracts portal.
Ribociclib for ER-Positive Metastatic Breast Cancer
Given that almost 20% of breast cancers are diagnosed in women 49 years of age and younger, expanding treatment options for this age group is a major objective. To that end, Tripathy and colleagues conducted a randomized, double-blind, phase III trial (MONALEESA-7 trial) to assess th…
Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)